Nonalcoholic fatty liver disease; who does not benefit from hepatic biopsy?

Gastroenterologia Polska

Volumn 12, Issue 3, 2005, Pages 209-213

  Hartleb, Marek ^a   Kajor, Maciej ^a   Gupińska Kajor, Monika ^a   Nowak, Andrzej ^a   Rudzki, Krystian ^a   Waluga, Marek ^a   Biernat, Łukasz ^a   Wandzel, Piotr ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Fibrosis; Liver biopsy; Nonalcoholic fatty liver disease; Steatohepatitis

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CHOLESTEROL; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; TRIACYLGLYCEROL;

ADULT; ARTICLE; CLINICAL ARTICLE; ECHOGRAPHY; FATTY LIVER; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATION; LIVER BIOPSY; LIVER FUNCTION TEST; LIVER SIZE; MALE; NONALCOHOLIC FATTY LIVER; STEATOSIS;

EID: 20644458545     PISSN: 12329886     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Angulo P., Keach J.C., Batts K.P., Lindor K.D.: Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology, 1999, 30, 1356-1362.
2. Dixon J.B., Bhathal P.S., O-Brien P.E.: Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology, 2001, 121, 91-100.
3. Kichian K., McLean R., Gramlich L.M., Bailey R.J., Bain V.G.: Nonalcoholic fatty liver disease in patients investigated for elevated liver enzymes. Can. J. Gastroenterol., 2003, 17, 38-42.
4. Ratziu V., Giral P., Charlotte F., Bruckert E., Thibault V., Theodorou I., Khalid L., Turpin G., Opolon P., Poynard T.: Liver fibrosis in overweight patients. Gastroenterology, 2000, 118, 1117-1123.
5. Cadranel J.F., Mathurin P.: Prothrombin index decrease: a useful and reliable marker of extensive fibrosis? Eur. J. Gastroenterol. Hepatol., 2002, 14, 1057-1059.
6. Bravo A.A., Sheth S.G., Chopra S.: Liver biopsy. N. Engl. J. Med., 2001, 344, 495-500.
7. Sorbi D., McGill D.B., Thistle J.L., Therneau T.M., Henry J., Lindor K.D.: An assessment of the role of liver biopsies in asymptomatic patients with chronic liver test abnormalities. Am. J. Gastroenterol., 2000, 95, 3206-3210.
8. Brunt E.M., Janney C.G., Di Bisceglie A.M., Neuschwander-Tetri B.A., Bacon B.R.: Nonaalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am. J. Gastroenterol., 1999, 94, 2467-2474.
9. Younossi Z.M., Diehl A.M., Ong P.J.: Nonalcoholic fatty liver disease: an agenda for clinical research. Hepatology, 2002, 35, 746-752.
10. Tacikowski T., Dzieniszewski J., Ciok J., Godziemba-Maliszewska E.: Niealkoholowa choroba stłuszczeniowa wa̧troby. Gastroenterol. Pol., 2004, 11, 271-278.
11. Clark J.M., Diehl A.M.: Nonalcoholic fatty liver disease: an underrecognized cause of cryptogenic cirrhosis. JAMA, 2003, 289, 3000-3004.
12. Day C.P., James O.F.W.: Steatohepatitis: a tale of two "hits"? Gastroenterology, 1998, 114, 842-845.
13. Teli M.R., James O.F.W., Burt A.D., Bennett M.K., Day C.P.: The natural history of nonalcoholic fatty liver: a follow-up study. Hepatology, 1995, 22, 1714-1719.
14. Harrison S.A., Torgerson S., Hayashi P.H.: The natural history of non-alcoholic fatty liver disease: a clinical histopathologic study. Am. J. Gastroenterol., 2003, 98, 2042-2047.
15. Li Z., Clark J., Diehl A.M.: The liver in obesity and type 2 diabetes mellitus. Clin. Liver Dis., 2002, 6, 867-877.
16. Powell E.E., Cooksley W.G., Hanson R., Searle J., Halliday J.W., Powell L.W.: The natural history of nonalcoholic steatohepatitis: a follow up study of forty-two patients for up to 21 years. Hepatology, 1990, 11, 74-80.
17. Khan S., Abadie M.A., Nair S.: Measurement of insulin resistance by QUCKI can predict the degree of fibrosis in non-alcoholic fatty liver disease (NAFLD). Am. J. Gastroenterol., 2003, 98, S100-S101 (abstract).
18. Matteoni C.A., Younossi Z.M., Gramlich T., Boparai N., Liu Y.C., McCullough A.J.: Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology, 1999, 116, 1413-1419.
19. Clark J.M., Diehl A.M.: Hepatic steatosis and type 2 diabetes mellitus. Curr. Diab. Rep., 2002, 2, 210-215.
20. Luyckx F.H., Lefebvre P.J., Scheen A.H.: Non-alcoholic steatohepatitis: association with obesity and insulin resistance, an influence of weight loss. Diabetes Metab., 2000, 26, 98-106.
21. Marchesini G., Brizi M., Bianchi G., Tomassetti S., Bugianezi E., Lenzi M., McCullough A.J., Natale S., Forlani G., Melchionda N.: Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes, 2001, 50, 1844-1850.
22. Marchesini G., Bugianesi E., Forlani G., Cerelli F., Lenzi M., Manini R., Natale S., Vanni E., Villanova N., Melchionda M., Rizzetto M.: Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology, 2003, 37, 917-923.
23. Susca M., Grassi A., Zauli D., Volta V., Lenzi M., Marchesini G., Bianchi F.B., Ballardini G.: Liver inflammatory cells, apoptosis, regeneration and stellate cell activation in non-alcoholic steatohepatitis. Dig. Liver Dis., 2001, 33, 768-777.
24. Mofrad P., Contos M.J., Hague M., Sargeant C., Fisher R.A., Luketic V.A., Sterling R.K., Shiffman M.L., Stravitz R.T., Sanyal A.J.: Clinical and histological spectrum of nonalcoholic fatty liver disease associated with normal ALT values. Hepatology, 2003, 37, 1286-1292.
25. Pohl A., Behling C., Oliver D., Kilani M., Monson P., Hassanein T.: Serum aminotransferase levels and platelet counts as predictors of degree of fibrosis in chronic hepatitis C virus infection. Am. J. Gastroenterol., 2001, 96, 3142-3146.